Beta Drugs Financials

NSE: BETA

₹2,123.90

up-down-arrow-94.60 (-4.26%)

As on 07-Sep-2026IST

Market cap

info icon

₹2,362 Cr

Revenue (TTM)

info icon

₹362 Cr

P/E Ratio

info icon

56.9

P/B Ratio

info icon

9

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Operating Revenue
362.36
295.71
227.11
183.84
116.12
90.81
Total Income
368.79
297.07
227.87
184.59
116.62
91.22
Total Expenditure
287.75
235.72
173.99
141.14
91.38
72.90
EBITDA
74.61
60.00
53.13
42.70
24.74
17.91
Depreciation
12.51
9.78
10.41
7.25
6.87
3.76
EBIT
62.09
50.22
42.72
35.44
17.87
14.15
Interest
6.99
2.82
2.41
1.90
2.42
2.59
Other Income
6.44
1.36
0.75
0.76
0.50
0.41
Exceptional Items
-4.57
--
--
--
--
--
Profit before Tax
56.97
48.75
41.06
34.30
15.95
11.97
Provision for Tax
14.55
12.32
10.34
9.47
4.23
2.56
Profit after Tax
42.42
36.44
30.72
24.83
11.72
9.42
Minority Interest
--
--
--
--
--
--
Share of Associate
--
--
--
--
--
--
Consolidated Profit
42.42
36.44
30.72
24.83
11.72
9.42

Liabilities (₹ Cr)

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Shareholder's Funds
197.10
157.12
122.88
92.34
68.61
57.11
Minority Interest
--
--
--
--
--
--
Non-Current Liabilities
134.58
10.90
11.32
15.86
14.95
13.21
Current Liabilities
113.39
94.40
69.70
54.85
36.59
37.99
Total Liabilities
446.89
263.83
205.11
163.73
120.79
108.48

Assets (₹ Cr)

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Non-Current Assets
103.33
74.82
69.54
60.21
48.82
50.97
Current Assets
341.73
187.60
134.37
102.83
71.33
57.34
Total Assets
446.89
263.83
205.11
163.73
120.79
108.48
Total Debt*
138.06
14.71
20.33
20.60
17.46
22.57
Net Current Assets
228.35
93.20
64.67
47.99
34.74
19.35
Contingent Liabilities
1.73
1.55
1.51
1.77
1.59
0.73

Cashflow (₹ Cr)

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Cash From Operating Activities
36.14
30.93
23.38
29.63
18.60
8.41
Cash Flow from Investing Activities
-35.72
-13.97
-19.07
-21.75
-5.85
-15.05
Cash from Financing Activities
117.97
-7.49
-2.47
-0.97
-7.71
8.73
Net Cash Inflow / Outflow
118.39
9.47
1.84
6.90
5.04
2.09

Financials Ratios

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Adjusted EPS (₹) info
42.02
36.10
30.43
24.60
11.61
9.33
Cash EPS (₹) info
54.42
45.79
40.74
31.78
18.42
13.05
Adjusted Book Value (₹) info
195.25
155.65
121.73
91.48
67.97
56.58
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
35.81
32.17
24.32
30.82
19.35
8.75
Free Cash Flow per Share (₹) info
-0.94
21.87
3.35
3.00
9.31
-8.41

Profitability Ratios

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
ROCE (%) info
25.23
32.74
33.94
36.38
22.17
20.71
ROE (%) info
23.95
26.03
28.55
30.85
18.65
19.21
ROA (%) info
11.99
15.63
16.74
17.53
10.26
9.82
EBIT Margin (%) info
17.14
16.98
18.81
19.28
15.39
15.58
Net Margin (%) info
11.50
12.27
13.48
13.45
10.05
10.32
Cash Profit Margin (%) info
15.16
15.63
18.11
17.45
16.02
14.51

Growth Ratios

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Revenue Growth (%) info
22.54
30.21
23.54
58.31
27.88
37.73
EBIT Growth (%) info
23.65
17.55
20.52
98.35
26.30
57.85
Net Profit Growth (%) info
16.42
18.62
23.73
111.76
24.53
17.11
EPS Growth (%) info
16.42
18.62
23.73
111.76
24.53
5.36
Book Value Growth (%) info
25.45
27.86
33.07
34.58
20.14
39.56

Valuation Ratios

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Price / Earnings info
45.35
31.00
19.62
21.90
9.84
4.08
Price / Book Value info
9.76
7.55
4.90
5.89
1.68
0.67
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
23.62
19.10
11.21
12.59
4.85
3.04
Close Price (₹) info
1,905.50
1,175.00
597.10
538.57
114.29
38.10
High Price (₹) info
2,215.24
1,519.05
975.62
661.90
134.10
118.10
Low Price (₹) info
1,047.62
578.38
520.05
113.33
37.14
35.24
Market Cap (₹ Cr) info
1,923.53
1,186.11
602.74
543.66
115.37
38.46

Solvency Ratios

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Debt to Equity info
0.70
0.09
0.17
0.22
0.25
0.40
Short term debt to equity ratio info
0.03
0.03
0.07
0.05
0.05
0.17
Current Ratio info
3.01
1.99
1.93
1.88
1.95
1.51
Quick Ratio info
2.49
1.55
1.49
1.47
1.57
1.21
Interest Coverage info
9.15
18.29
18.00
19.06
7.59
5.63

Operating Efficiency Ratios

Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16 Mar-15
Debtors to sales (%) info
28.31
26.80
27.62
24.58
29.17
35.16
Asset Turnover info
1.02
1.27
1.24
1.30
1.02
0.95
Receivable days info
91.57
87.61
86.71
78.48
103.42
114.47
Inventory Days info
55.19
49.64
42.67
38.24
44.62
43.97
Payable days info
139.01
121.55
124.66
101.32
108.61
113.58
Cash Conversion Cycle info
7.75
15.70
4.72
15.40
39.42
44.85
loading...
loading...
loading...
loading...